Skip to main content
SpringerLink
Log in

Medical Treatment: Alternative Medicine and Glaucoma

  • Chapter
  • First Online:
Pearls of Glaucoma Management

  • 1104 Accesses

Abstract

When patients inquire about the relationship between lifestyle factors and glaucoma the physician should seize upon this interaction to educate them about their disease.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Kass MA, Heuer DK, Higginbotham EJ, et al. The ocular hypertension treatment study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol. 2002;120:701–13.

    Article  PubMed  Google Scholar 

  2. Miglior S, Zeyen T, Pfeiffer N, et al. Results of the European glaucoma prevention study. Ophthalmology. 2005;112:366–75.

    Article  PubMed  Google Scholar 

  3. Collaborative Normal-Tension Glaucoma Study Group. Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressures. Am J Ophthalmol. 1998;126:487–97.

    Article  Google Scholar 

  4. Heijl A, Leske MC, Bengtsson B, et al. Reduction of intraocular pressure and glaucoma progression: results from the early manifest glaucoma trial. Ophthalmology. 2002;120:1268–79.

    Google Scholar 

  5. Garway-Heath DF, Crabb DP, Bunce DP, et al. Latanoprost for the treatment of open-angle glaucoma (UKGTS): a randomized, multicenter, placebo-controlled trial. Lancet. 2014;385(9975):1295–304.

    Article  PubMed  Google Scholar 

  6. Krupin T, Liebmann JM, Greenfield DS, et al. A randomized trial of brimonidine versus timolol in preserving visual function: results from the low-pressure glaucoma treatment study. Am J Ophthalmol. 2011;151:672–81.

    Article  Google Scholar 

  7. The Glaucoma Laser Trial Research Group. The Glaucoma Laser Trial (GLT): 2. Results of argon laser trabeculoplasty versus topical medicines. Ophthalmology. 1990;97:1403–13.

    Article  Google Scholar 

  8. The Advanced Glaucoma Intervention Study (AGIS): 4. Comparison of treatment outcomes within a race. Seven-year results. Ophthalmology. 1998;105:1146–64.

    Google Scholar 

  9. Lichter PR, Musch DC, Gillespie BW, et al. Interim clinical outcomes in the collaborative initial glaucoma treatment Study comparing initial treatment randomized to medications or surgery. Ophthalmology. 2001;108:1943–53.

    Article  CAS  PubMed  Google Scholar 

  10. Ohguro H, Ohguro I, Tanaka S. Two-year randomized, placebo-controlled study of black currant anthocyanins on visual field in glaucoma. Ophthalmologica. 2012;228:26–35.

    Article  CAS  PubMed  Google Scholar 

  11. Yoshida K, Ohguro I, Ohguro H. Black currant anthocyanins normalized abnormal levels of serum concentrations of endothelin-1 in patients with glaucoma. J Ocul Pharmacol Ther. 2013;29:480–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Schuman JS, Massicotte EC, Connolly S, et al. Increased intraocular pressure and visual field defects in high resistance wind instrument players. Ophthalmology. 2000;107:127–33.

    Article  CAS  PubMed  Google Scholar 

  13. Schmidtmann G, Jahnke S, Seidel EJ, et al. Intraocular pressure fluctuations in professional brass and woodwind musicians during common playing conditions. Graefes Arch Clin Exp Ophthalmol. 2011;249:895–901.

    Article  PubMed  Google Scholar 

  14. Cramer H, Krucoff C, Dobos G. Adverse events associated with yoga: a systematic review of published case reports and case series. PLoS One. 2013;8(10), e75515.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Fleischhauer JC, Mitchell CH, Stamer WD, et al. Common actions of adenosine receptor agonists in modulating human trabecular meshwork cell transport. J Membr Biol. 2003;193:121–36.

    Article  CAS  PubMed  Google Scholar 

  16. Karl MO, Fleischhauer JC, Stamer WD, et al. Differential P1-purinergic modulation of human Schlemm’s canal inner-wall cells. Am J Physiol Cell Physiol. 2005;288:C784–94.

    Article  CAS  PubMed  Google Scholar 

  17. Peczon JD, Grant WM. Sedatives, stimulants, and intraocular pressure in glaucoma. Arch Ophthalmol. 1964;72:178–88.

    Article  CAS  PubMed  Google Scholar 

  18. Ajayi OB, Ukwade MT. Caffeine and intraocular pressure in a Nigerian population. J Glaucoma. 2001;10:25–31.

    Article  CAS  PubMed  Google Scholar 

  19. Avisar R, Avisar E, Weinberger D. Effect of coffee consumption on intraocular pressure. Ann Pharmacother. 2002;36:992–5.

    Article  PubMed  Google Scholar 

  20. Higginbotham EJ, Kilimanjaro HA, Wilensky JT, et al. The effect of caffeine on intraocular pressure in glaucoma patients. Ophthalmology. 1989;96:624–6.

    Article  CAS  PubMed  Google Scholar 

  21. Okimi PH, Sportsman S, Pickard MR, Fritsche MB. Effects of caffeinated coffee on intraocular pressure. Appl Nurs Res. 1991;4:72–6.

    Article  CAS  PubMed  Google Scholar 

  22. Jiwani AZ, Rhee DJ, Brauner SC, et al. Effect of caffeinated coffee consumption on intraocular pressure, ocular perfusion pressure and ocular pulse amplitude: a randomized controlled trial. Eye (Lond). 2012;26:1120–30.

    Article  Google Scholar 

  23. Ricklefs G. Studies on the ways of life of glaucoma patients. Doc Ophthalmol. 1968;25:43–99.

    Article  CAS  PubMed  Google Scholar 

  24. Ricklefs G. Effect of caffeine containing tablets and Coca-Cola on the intraocular pressure of patients without glaucoma and patients with regulated glaucoma. Klin Monbl Augenheilkd. 1969;154:546–51.

    CAS  PubMed  Google Scholar 

  25. Kang JH, Willett WC, Rosner BA, et al. Caffeine consumption and the risk of primary open-angle glaucoma: a prospective cohort study. Invest Ophthalmol Vis Sci. 2008;49:1924–31.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Pasquale LR, Wiggs JL, Willett WC, Kang JH. The relationship between caffeine and coffee consumption and exfoliation glaucoma and glaucoma suspect: a prospective study in two cohorts. Invest Ophthalmol Vis Sci. 2012;53:6427–33.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Marcus DF, Krupin T, Podos SM, et al. The effect of exercise on intraocular pressure. I. Human beings. Invest Ophthalmol. 1970;9:749–52.

    CAS  PubMed  Google Scholar 

  28. Sargent RG, Blair SN, Magun JC, et al. Physical fitness and intraocular pressure. Am J Optom Physiol Opt. 1981;58:460–6.

    Article  CAS  PubMed  Google Scholar 

  29. McDaniel DR, Tribbey CL, Tobias GS. Effects of moderate exercise on intraocular pressure. Am J Optom Physiol Opt. 1983;60:154–7.

    Article  CAS  PubMed  Google Scholar 

  30. Buckingham T, Young R. The rise and fall of intraocular pressure: the influence of physiological factors. Ophthalmic Physiol Opt. 1986;6:95–9.

    Article  CAS  PubMed  Google Scholar 

  31. Passo MS, Goldberg L, Elliot DL, et al. Exercise training reduces intraocular pressure among subjects suspected of having glaucoma. Arch Ophthalmol. 1991;109:1096–8.

    Article  CAS  PubMed  Google Scholar 

  32. Qureshi IA, Wu XD, Xi XR, et al. Resting intraocular pressure of steel factory workers is related to their physical fitness. Ind Health. 1997;35:259–63.

    Article  CAS  PubMed  Google Scholar 

  33. Vieira GM, Oliveira HB, de Andrade DT, et al. Intraocular pressure variation during weight lifting. Arch Ophthalmol. 2006;124:1251–4.

    Article  PubMed  Google Scholar 

  34. Chromiak JA, Abadie BR, Braswell RA, et al. Resistance training exercises acutely reduce intraocular pressure in physically active men and women. J Strength Cond Res. 2003;17:715–20.

    PubMed  Google Scholar 

  35. Williams PT. Relationship of incident glaucoma versus physical activity and fitness in male runners. Med Sci Sports Exerc. 2009;41:1566–72.

    Article  PubMed  PubMed Central  Google Scholar 

  36. Smith DL, Kao SF, Rabbani R, et al. The effects of exercise on intraocular pressure in pigmentary glaucoma patients. Ophthalmic Surg. 1989;20:561–7.

    CAS  PubMed  Google Scholar 

  37. Haynes WL, Johnson AT, Alward WL. Effects of jogging exercise on patients with the pigmentary dispersion syndrome and pigmentary glaucoma. Ophthalmology. 1992;99:1096–103.

    Article  CAS  PubMed  Google Scholar 

  38. Tamaki Y, Araie M, Nagahara M, et al. The acute effects of cigarette smoking on human optic nerve head and posterior fundus circulation in light smokers. Eye (Lond). 2000;14(Pt 1):67–72.

    Article  Google Scholar 

  39. Lee AJ, Rochtchina E, Wang JJ, et al. Does smoking affect intraocular pressure? Findings from the Blue Mountains eye study. J Glaucoma. 2003;12:209–12.

    Article  PubMed  Google Scholar 

  40. Klein BE, Klein R, Ritter LL. Relationship of drinking alcohol and smoking to prevalence of open-angle glaucoma. The Beaver Dam Eye Study. Ophthalmology. 1993;100:1609–13.

    Article  CAS  PubMed  Google Scholar 

  41. Wilson MR, Hertzmark E, Walker AM, et al. A case-control study of risk factors in open angle glaucoma. Arch Ophthalmol. 1987;105:1066–71.

    Article  CAS  PubMed  Google Scholar 

  42. Quigley HA, West SK, Rodriguez J, et al. The prevalence of glaucoma in a population-based study of Hispanic subjects: Proyecto VER. Arch Ophthalmol. 2001;119:1819–26.

    Article  CAS  PubMed  Google Scholar 

  43. Kang JH, Pasquale LR, Rosner BA, et al. Prospective study of cigarette smoking and the risk of primary open-angle glaucoma. Arch Ophthalmol. 2003;121:1762–8.

    Article  PubMed  Google Scholar 

  44. Gwira JA, Vistamehr S, Shelsta H, et al. Factors associated with failure to follow up after glaucoma screening: a study in an African American population. Ophthalmology. 2006;113:1315–9.

    Article  PubMed  Google Scholar 

  45. Musch DC, Gillespie BW, Niziol LM, et al. Factors associated with intraocular pressure before and during 9 years of treatment in the collaborative initial glaucoma treatment study. Ophthalmology. 2007;115:927–33.

    Article  PubMed  PubMed Central  Google Scholar 

  46. Ye J, He J, Wang C, et al. Smoking and risk of age-related cataract: a meta-analysis. Invest Ophthalmol Vis Sci. 2012;53:3885–95.

    Article  PubMed  Google Scholar 

  47. Chakravarthy U, Wong TY, Flecther A, et al. Clinical risk factors for age-related macular degeneration: a systematic review and meta-analysis. BMC Ophthalmol. 2010;10:31.

    Article  PubMed  PubMed Central  Google Scholar 

  48. Iestra JA, Kromhout D, van der Schouw YT, et al. Effect size estimates of lifestyle and dietary changes on all-cause mortality in coronary artery disease patients: a systematic review. Circulation. 2005;112:924–34.

    Article  CAS  PubMed  Google Scholar 

  49. Wen CP, Cheng TY, Lin CL, et al. The health benefits of smoking cessation for adult smokers and for pregnant women in Taiwan. Tob Control. 2005;14 Suppl 1:i56–61.

    Article  PubMed  PubMed Central  Google Scholar 

  50. Peczon J, Grant W. Glaucoma, alcohol, and intraocular pressure. Arch Ophthalmol. 1965;73:495–501.

    Article  Google Scholar 

  51. Houle RE, Grant WM. Alcohol, vasopressin, and intraocular pressure. Invest Ophthalmol. 1967;6:145–54.

    CAS  PubMed  Google Scholar 

  52. Giurlani BP, Obie LG, Petersen CG, et al. Alcohol and open angle glaucoma-influence on detection, IOP, BP/IOP ratios. J Am Optom Assoc. 1978;49:409–16.

    CAS  PubMed  Google Scholar 

  53. Harris A, Swartz D, Engen D, et al. Ocular hemodynamic effects of acute ethanol ingestion. Ophthalmic Res. 1996;28:193–200.

    Article  CAS  PubMed  Google Scholar 

  54. Leydhecker W, Krieglstein GK, Uhlich E. Experimental investigations on the mode of action of alcoholic liquor on the intraocular pressure (author’s transl). Klin Monbl Augenheilkd. 1978;173:75–9.

    CAS  PubMed  Google Scholar 

  55. Leske MC, Warheit-Roberts L, Wu SY. Open-angle glaucoma and ocular hypertension: the long island glaucoma case-control study. Ophthalmic Epidemiol. 1996;3:85–96.

    Article  CAS  PubMed  Google Scholar 

  56. Lin HY, Hsu WM, Chou P, et al. Intraocular pressure measured with a noncontact tonometer in an elderly Chinese population: the Shihpai Eye Study. Arch Ophthalmol. 2005;123:381–6.

    Article  PubMed  Google Scholar 

  57. Yoshida M, Ishikawa M, Kokaze A, et al. Association of life-style with intraocular pressure in middle-aged and older Japanese residents. Jpn J Ophthalmol. 2003;47:191–8.

    Article  PubMed  Google Scholar 

  58. Kang JH, Willett WC, Rosner BA, et al. Prospective study of alcohol consumption and the risk of primary open-angle glaucoma. Ophthalmic Epidemiol. 2007;14:141–7.

    Article  PubMed  Google Scholar 

  59. Fan BJ, Leung YF, Wang N, et al. Genetic and environmental risk factors for primary open-angle glaucoma. Chin Med J (Engl). 2004;117:706–10.

    CAS  Google Scholar 

  60. Leske MC, Connell AM, Wu SY, et al. Risk factors for open-angle glaucoma. The Barbados Eye Study. Arch Ophthalmol. 1995;113:918–24.

    Article  CAS  PubMed  Google Scholar 

  61. Kahn HA, Milton RC. Alternative definitions of open-angle glaucoma. Effect on prevalence and associations in the Framingham eye study. Arch Ophthalmol. 1980;98:2172–7.

    Article  CAS  PubMed  Google Scholar 

  62. Anthony D, George P, Eaton CB. Cardiac risk factors: environmental, sociodemographic and behavioral cardiovascular risk factors. FP Essent. 2014;421:16–20.

    PubMed  Google Scholar 

  63. Gonzales JF, Barnard ND, Jenkins DTT, et al. Applying the precautionary principle to nutrition and cancer. J Am Coll Nutr. 2014;33:239–46.

    Article  CAS  PubMed  Google Scholar 

  64. Kumar DM, Agarwal N. Oxidative stress in glaucoma: a burden of evidence. J Glaucoma. 2007;16:334–43.

    Article  PubMed  Google Scholar 

  65. Kang JH, Pasquale LR, Willett W, et al. Antioxidant intake and primary open-angle glaucoma: a prospective study. Am J Epidemiol. 2003;158:337–46.

    Article  PubMed  Google Scholar 

  66. Wang SY, Sing K, Lin SC. Glaucoma and vitamins A, C, and E supplement intake and serum levels in a population-based sample of the United States. Eye (Lond). 2013;27:487–94.

    Article  CAS  Google Scholar 

  67. Giaconi JA, Yu F, Stone KL, et al. The association of consumption of fruits/vegetables with decreased risk of glaucoma among older African-American women in the study of osteoporotic fractures. Am J Ophthalmol. 2012;154:635–44.

    Article  PubMed  PubMed Central  Google Scholar 

  68. Kang JH, Pasquale LR, Willett WC, et al. Dietary fat consumption and primary open-angle glaucoma. Am J Clin Nutr. 2004;79:755–64.

    CAS  PubMed  Google Scholar 

  69. Toutas T, Birke MT, Kruse FE, et al. Preventive effects of omega-3 and omega-6 fatty acids on peroxide mediated oxidative stress responses in primary human trabecular meshwork cells. PLoS One. 2012;7:e31340.

    Article  Google Scholar 

  70. Nguyen CT, Vingrys AJ, Bui BV. Dietary ω-3 deficiency and IOP insult are additive risk factors for ganglion cell dysfunction. J Glaucoma. 2013;22:269–77.

    Article  PubMed  Google Scholar 

  71. Rhee DJ, Spaeth GL, Myers JS, et al. Prevalence of the use of complementary and alternative medicine for glaucoma. Ophthalmology. 2002;109:438–43.

    Article  PubMed  Google Scholar 

  72. Wan DJ, Daniel S, Kassam F, et al. Survey of complementary and alternative medicine use in glaucoma patients. J Glaucoma. 2012;21:79–82.

    PubMed  Google Scholar 

  73. Porcella A, Maxia C, Gessa GL, et al. The human eye expresses high levels of CB1 cannabinoid receptor mRNA and protein. Eur J Neurosci. 2000;12:1123–7.

    Article  CAS  PubMed  Google Scholar 

  74. Flach AJ. Delta-9-tetrahydrocannabinol (THC) in the treatment of end-stage open-angle glaucoma. Trans Am Ophthalmol Soc. 2002;100:215–22; discussion 222–4.

    PubMed  PubMed Central  Google Scholar 

  75. Green K. Marijuana smoking vs. cannabinoids for glaucoma therapy. Arch Ophthalmol. 1998;116:1433–7.

    Article  CAS  PubMed  Google Scholar 

  76. Jampel H. American Glaucoma Society position statement: marijuana and the treatment of glaucoma. J Glaucoma. 2010;19:75–6.

    Article  PubMed  Google Scholar 

  77. Buys YM, Rafuse PE. Canadian Ophthalmological Society policy statements on the medical use of marijuana for glaucoma. Can J Ophthalmol. 2010;45:324–6.

    Article  PubMed  Google Scholar 

  78. Tan MS, Yu JT, Tan CC, et al. Efficacy and adverse effects of ginko biloba for cognitive impairment and dementia: a systematic review and meta-analysis. J Alzheimers Dis. 2015;43:589–603.

    CAS  PubMed  Google Scholar 

  79. Quaranta L, Bettelli S, Uva MG, et al. Effect of Ginkgo biloba extract on preexisting visual field damage in normal tension glaucoma. Ophthalmology. 2003;110:359–62; discussion 362–4.

    Article  PubMed  Google Scholar 

  80. Guo X, Kong X, Huang R, et al. Effect of ginko biloba on visual field and contrast sensitivity in Chinese patients with normal tension glaucoma: a randomized, crossover clinical trial. Invest Ophthalmol Vis Sci. 2014;55:110–6.

    Article  PubMed  Google Scholar 

  81. Law SK, Li T. Acupuncture for glaucoma. Cochrane Database Syst Rev. 2013;5, CD006030.

    PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Ophthalmology, Harvard Medical School, 243 Charles Street, Boston, MA, 02114, USA

    Louis R. Pasquale

  2. Division of Network Medicine, Brigham and Women’s Hospital, Harvard Medical School, 181 Longwood Avenue, Boston, MA, 20115, USA

    Louis R. Pasquale

Authors
  1. Louis R. Pasquale
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Louis R. Pasquale .

Editor information

Editors and Affiliations

  1. David Geffen School of Medicine, University of California at Los Angeles, Veterans Health Administration of Greater Los Angeles, Jules Stein Eye Institute, David Geffen School of Medicine, University of California at Los Angeles, Veterans Health Administration of Greater Los Angeles, Los Angeles, California, USA

    JoAnn A. Giaconi

  2. David Geffen School of Medicine, University of California at Los Angeles, Jules Stein Eye Institute, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, California, USA

    Simon K. Law

  3. David Geffen School of Medicine, University of California at Los Angeles,, Jules Stein Eye Institute, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, California, USA

    Kouros Nouri-Mahdavi

  4. David Geffen School of Medicine, University of California at Los Angeles,, Jules Stein Eye Institute, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, California, USA

    Anne L. Coleman

  5. David Geffen School of Medicine, University of California at Los Angeles,, Jules Stein Eye Institute, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, California, USA

    Joseph Caprioli

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Pasquale, L.R. (2016). Medical Treatment: Alternative Medicine and Glaucoma. In: Giaconi, J., Law, S., Nouri-Mahdavi, K., Coleman, A., Caprioli, J. (eds) Pearls of Glaucoma Management. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-49042-6_31

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-49042-6_31

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-49040-2

  • Online ISBN: 978-3-662-49042-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation